Complexes of nickel(II) with purine bases: relaxation spectra.

R. Karpel,K. Kustin,M. Wolff

DOI: https://doi.org/10.1021/J100676A013

1971-03-18

Abstract:

What problem does this paper attempt to address?

Poor Sleep Quality And Excessive Daytime Sleepiness Are Associated With Adverse Health Outcomes In Patients With Heart Failure

Jia-Rong Wu,Chin-Yen Lin,Terry Lennie,Debra Moser

DOI: https://doi.org/10.1016/j.cardfail.2023.10.230

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Background Poor sleep quality is common among patients with heart failure (HF), and results in excessive daytime sleepiness. Both poor sleep quality and excessive daytime sleepiness are associated with poor health outcomes, but the extent to which this relationship exists in patients with HF is unknown. Objective To explore the associations among sleep quality, excessive daytime sleepiness, and cardiac event-free survival in patients with HF. Method This was a prospective, longitudinal study of 210 patients with HF (female 33%, age 62±12, ischemic HF: 45%, NYHA class III/IV: 37%). Sleep quality was measured using the Pittsburg Sleep Quality Index. Daytime sleepiness was measured by the Epworth Sleepiness Scale. HF hospitalizations and cardiac mortality were followed at least one year and obtained by patient interview, medical record review, and death certificate review. Chi-square, ANOVA, logistic regression, and survival analyses (i.e., Kaplan-Meier with log rank tests and Cox regression) were used for data analysis. Results One hundred and twelve patients (53%) had poorer sleep quality. Sixty-four patients (31%) had excessive daytime sleepiness. Compared to those with better sleep quality, patients with poorer sleep quality were 2.3 times more likely to have excessive daytime sleepiness (P =.008). Patients were divided into 4 groups based on sleep quality and daytime sleepiness: 1) better sleep quality without excessive daytime sleepiness; 2) better sleep quality with excessive daytime sleepiness; 3) poorer sleep quality without excessive daytime sleepiness; and 4) poorer sleep quality with excessive daytime sleepiness. Both poorer sleep quality and excessive daytime sleepiness independently predicted worse cardiac event-free survival (both P < .05). Cardiac event-free survival was worst in those with both poorer sleep quality and excessive daytime sleepiness compared to patients in any of the other three groups. Patients with poorer sleep quality and excessive daytime sleepiness had 3.3 times higher risk of a cardiac event compared to those with better sleep quality or without excessive daytime sleepiness (P = .004, Figure). Race and New York Heart Association functional class (NYHA) were significantly different among the four sleep quality and daytime sleepiness groups. Conclusion Patients with poorer sleep quality and excessive daytime sleepiness were at highest risk of experiencing a cardiac event. Patients with HF need to be screened for their sleep problems and interventions need to be developed to target high risk patients with poor sleep quality and excessive daytime sleepiness to alleviate poor outcomes in patients with HF.

cardiac & cardiovascular systems
HISTIOCYTOSIS X WITH CATECHOLAMINE EXCESS

D. Ganick,C. Green,M. Edmonson,G. Hafez

DOI: https://doi.org/10.1111/j.1651-2227.1982.tb09500.x

1982-07-01

Abstract:ABSTRACT. A case of isolated histiocytosis X of the liver is described in a 12‐month‐old child. The patient's symptomcomplex were characterized by fever, tachycardia, hypertension and odd posturing resembling the clinical picture of pheochromocytoma. An extensive workup failed to demonstrate a catecholamine secreting tumor and only histiocytosis X of the liver was found.
[Effect of Objective Daytime Sleepiness on Heart Rate Variability in Patients With Obstructive Sleep Apnea].

Yuan Shi,Taomei Li,L. Tan,R. Ren,Xiangdong Tang,Mengmeng Zhang,Ye Zhang,Jie Zhu

DOI: https://doi.org/10.12182/20230360202

2023-03-01

Abstract:Objective Excessive daytime sleepiness (EDS) is associated with cardiovascular events in patients with obstructive sleep apnea (OSA). Our study explored the correlation between objective daytime sleepiness assessed with daytime multiple sleep latency tests (MSLT) and heart rate variability (HRV) in OSA patients. The results may provide insight into possible mechanisms underlying increased risk of cardiovascular events in patients with OSA. Methods A retrospective analysis was conducted with the data of 139 patients with OSA and 35 patients with primary snoring. All subjects underwent polysomnography (PSG) and MSLT at West China Hospital between January 2019 and May 2022. We used mean sleep latency (MSL) to measure the severity of EDS and to categorize OSA patients into three groups, severe EDS, light EDS, and non-EDS, with MSL of less than 5 minutes, 5 to 10 minutes, and greater than 10 minutes as the respective defining criteria for classification. A comparison of sleep structure, clinical characteristics, and HRV parameters was performed in order to evaluate the difference between OSA subgroups with varying levels of objective EDS and the primary snoring group. In addition, we also analyzed the correlation between MSL and HRV parameters. Results Severe EDS patients had higher values of standard deviation of all N-N intervals (SDNN), total spectral power (TOT), and low-frequency power (LF) as compared to non-EDS patients, which was indicative of sympathetic stimulation ( P<0.05). Additionally, high-frequency power (HF) was also higher in severe EDS patients, which indicated decreased parasympathetic drive. A significantly positive correlation was found between MSL and the values of SDNN, TOT, LF, and HF in OSA patients. Conclusion OSA patients with objective EDS have elevated sympathetic drive and decreased parasympathetic drive. A positive correlation was found between this change in neural activity and the shortening of MSL.

Medicine
Sleep apnea is associated with reduced in-hospital mortality in patients admitted for acute heart disease

Baty,F.,Moser,M.,Kleger,G.-R.,Maeder,M.,Rickli,H.,Schoch,O.,Brutsche,M.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5350

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: Sleep apnea (SA) is an independent risk factor for cardiovascular diseases. The impact of SA on the outcome of patients hospitalized for cardiovascular diseases is controversial. Recent studies indicated fewer fatal cardiac events associated with SA in a setting where comorbidities may play an important role. Aims: The aim of our study was to further investigate the in-hospital mortality of patients hospitalized for acute cardiovascular diseases with or without SA. Methods: Data were extracted from a Swiss-wide hospitalization database. All patients hospitalized for acute heart disease were extracted. Among those patients, all patients with a co-diagnosis of SA were extracted together with a 1:1 matched control population without SA. The impact of SA together with other comorbidities was investigated using competing risks survival analysis. Results: Between 2010 and 2020, 744,455 hospitalizations due to acute heart disease were monitored in Switzerland among which 21,904 had SA. Patients with SA had a longer length of stay, were more often rehospitalized, had more comorbidities but had a lower in-hospital mortality compared to controls (HR: 0.40 [95% CI: 0.35 to 0.45]; p<0.001). Several comorbidities significantly interacted with SA. Obesity and hypertension were independently associated with a lower in-hospital mortality in both SA and non- SA. Other comorbidities were associated with an increased in-hospital mortality. Shock and acute myocardial infarction were more frequent and significantly more harmful in non-SA. Conclusions: SA was associated with a lower in-hospital mortality in patients with acute heart disease. Comorbidities contributed to the protective effect of SA.

respiratory system
Obstructive sleep apnoea and nocturnal atrial fibrillation in patients with ischaemic heart disease

Silin Kuang,Yiong Huak Chan,Serene Wong,See Meng Khoo

DOI: https://doi.org/10.4103/singaporemedj.smj-2021-293

2024-02-16

Singapore Medical Journal

Abstract:Abstract Introduction: Arrhythmias, especially atrial fibrillation (AF) and ventricular arrhythmias, are independent risk factors of mortality in patients with ischaemic heart disease (IHD). While there is a growing body of evidence that suggests an association between obstructive sleep apnoea (OSA) and cardiac arrhythmias, evidence on this relationship in patients with IHD has been scant and inconsistent. We hypothesised that in patients with IHD, severe OSA is associated with an increased risk of nocturnal arrhythmias. Methods: We studied 103 consecutive patients with IHD who underwent an overnight polysomnography. Exposed subjects were defined as patients who had an apnoea–hypopnoea index (AHI) ≥30/h (severe OSA), and nonexposed subjects were defined as patients who had an AHI <30/h (nonsevere OSA). All electrocardiograms (ECGs) were interpreted by the Somte ECG analysis software and confirmed by a physician blinded to the presence or absence of exposure. Arrhythmias were categorised as supraventricular and ventricular. Arrhythmia subtypes (ventricular, atrial and conduction delay) were analysed as dichotomous outcomes using multiple logistic regression models. Results: Atrial fibrillation and AF/flutter (odds ratio 13.5, 95% confidence interval 1.66–109.83; P = 0.003) were found to be more common in the severe OSA group than in the nonsevere OSA group. This association remained significant after adjustment for potential confounders. There was no significant difference in the prevalence of ventricular and conduction delay arrhythmias between the two groups. Conclusion: In patients with IHD, there was a significant association between severe OSA and nocturnal AF/flutter. This underscores the need to evaluate for OSA in patients with IHD, as it may have important implications on clinical outcomes.

medicine, general & internal
0490 Sleep Apnea Severity Has a U-shaped Association with All-cause Mortality

Mehrnaz Azarian,Amin Ramezani,Amir Sharafkhaneh,Arash Maghsoudi,Melissa Jones,Javad Razjouyan

DOI: https://doi.org/10.1093/sleep/zsae067.0490

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Sleep apnea (SA) severity is determined by apnea hypopnea index (AHI). The interaction between SA and mortality is debated. We explored the relationship between severity of SA and mortality. We further investigated the effect of age on this relationship. Methods We developed an Natural Language Processing program (evaluated with 972 notes manually annotated notes) to extract apnea hypopnea index (AHI) from text of physician interpretation of sleep studies, i.e., polysomnograms and home sleep apnea testing, performed at the veteran health administration (VA) from 2000-2022. We grouped the participants to no-SA (n-SA, AHI< 5), mild to moderate SA (m-SA, 5 < AHI < 30) and severe SA (s-SA, AHI>30). We further stratified the cohort based on age: Young, < 40; Middle, >40 and < 65; and older, >65 adults. Using logistic regression, we estimated odds ratio (aOR) for mortality adjusted for age, sex, race, ethnicity, and Charlson-Comorbidity Index using m-SA as reference. Results 427,587 patients (age, 55.1±14.6 years; BMI, 32.7±6.2; male, 90.5% and 65% male) had at least one documented AHI. The NLP algorithm achieved to high recall (89%), specificity (91%) and F1-score (88%). Mortality rates were 10.8%, 7.7%, and 13.4% in the n-SA, m-SA, and s-SA, respectively. aOR for all-cause mortality rates in Young for n-SA was 1.08 (0.94-1.20) vs s-SA 1.20 (1.08-1.26); in Middle Age for n-SA was 1.40 (1.33-1.41) vs s-SA 1.20 (1.15-1.24); and in Older was for n-SA 1.49 (1.45-1.52), s-SA 1.04 (1.00-1.08). Conclusion All-cause mortality rate relates to the severity of SA in a U-Shaped appearance. The U-shape appearance increases markedly with age. Further investigations into mechanisms of the U-Shaped appearance is needed. Support (if any) Supported by NIH-NHLBI-K25 funding (#1K25HL152006-01 [J.R.]); seed funding by AHBPCE (#FY2024-002 [J.R.]); and Center for Innovations in Quality, Effectiveness, and Safety (CIN 13-413), Michael E. DeBakey VA Medical Center, Houston, TX.

neurosciences,clinical neurology
Heart rate variability analysis in obstructive sleep apnea patients with daytime sleepiness

Seren Ucak,Hasthi U Dissanayake,Philip de Chazal,Yu Sun Bin,Kate Sutherland,Bianca Setionago,Benjamin Tong,Brendon J Yee,Kristina Kairaitis,John R Wheatley,Amanda J Piper,Peter A Cistulli

DOI: https://doi.org/10.1093/sleep/zsae075

IF: 6.313

2024-03-26

SLEEP

Abstract:Abstract Study Objectives Recent studies suggest that sleepy patients with obstructive sleep apnea (OSA) are at higher risk for incident cardiovascular disease. This study assessed cardiac autonomic function in sleepy versus non-sleepy patients with OSA using heart rate variability (HRV) analysis. We hypothesized that HRV profiles of sleepy patients would indicate higher cardiovascular risk. Methods Electrocardiograms (ECG) derived from polysomnograms (PSG) collected by the Sydney Sleep Biobank were used to study HRV in groups of sleepy (ESS ≥ 10) and non-sleepy OSA patients (ESS < 10). HRV parameters were averaged across available ECG signals during N2 sleep. Results A total of 421 patients were evaluated, with a mean age of 54 (14) years, body mass index of 33 (9) kg/m2, apnea–hypopnea index of 21 (28) events/h, and 66% male. The sleepy group consisted of 119 patients and the non-sleepy group 302 patients. Sleepy patients exhibited lower HRV values for: root mean square successive difference (RMSSD, p = 0.028), total power (TP, p = 0.031), absolute low frequency (LF, p = 0.045), and high-frequency (HF, p = 0.010) power compared to non-sleepy patients. Sleepy patients with moderate-to-severe OSA exhibited lower HRV values for: (RMSSD, p = 0.045; TP, p = 0.052), absolute LF (p = 0.051), and HF power (p = 0.025). There were no differences in other time and frequency domain HRV markers. Conclusions This study shows a trend toward parasympathetic withdrawal in sleepy OSA patients, particularly in moderate-to-severe cases, lending mechanistic support to the link between the sleepy phenotype and CVD risk in OSA.

neurosciences,clinical neurology
Gene directed enzyme prodrug therapy for cancer.

Kerr,Young,Searle,McNeish

DOI: https://doi.org/10.1016/S0169-409X(97)00033-1

IF: 16.1

1997-07-07

Advanced Drug Delivery Reviews

Abstract:
Objective Assessment of Daytime Napping and Incident Heart Failure in 1140 Community-Dwelling Older Adults: A Prospective, Observational Cohort Study.

Peng Li,Arlen Gaba,Patricia M. Wong,Longchang Cui,Lei Yu,David A. Bennett,Aron S. Buchman,Lei Gao,Kun Hu

DOI: https://doi.org/10.1161/jaha.120.019037

IF: 6.106

2021-06-04

Journal of the American Heart Association

Abstract:Background Disrupted nighttime sleep has been associated with heart failure (HF). However, the relationship between daytime napping, an important aspect of sleep behavior commonly seen in older adults, and HF remains unclear. We sought to investigate the association of objectively assessed daytime napping and risk of incident HF during follow‐up. Methods and Results We studied 1140 older adults (age, 80.7±7.4 [SD] years; female sex, 867 [76.1%]) in the Rush Memory and Aging Project who had no HF at baseline and were followed annually for up to 14 years. Motor activity (ie, actigraphy) was recorded for ≈10 days at baseline. We assessed daytime napping episodes between 9 am and 7 pm objectively from actigraphy using a previously published algorithm for sleep detection. Cox proportional hazards models examined associations of daily napping duration and frequency with incident HF. Eighty‐six participants developed incident HF, and the mean onset time was 5.7 years (SD, 3.4; range, 1–14). Participants who napped longer than 44.4 minutes (ie, the median daily napping duration) showed a 1.73‐fold higher risk of developing incident HF than participants who napped 1.7 times/day (ie, the median daily napping frequency) showed a 2.20‐fold increase compared with participants who napped <1.7 times/day. These associations persisted after adjustment for covariates, including nighttime sleep, comorbidities, and cardiovascular disease/risk factors. Conclusions Longer and more frequent objective napping predicted elevated future risk of developing incident HF. Future studies are needed to establish underlying mechanisms. Nonstandard Abbreviation and Acronym MAP Memory and Aging Project Clinical Perspective What Is New? Association of daytime napping and future heart failure incidence was examined on the basis of objectively defined daytime napping duration and frequency using actigraphy. Longer and more frequent objective daytime napping were associated with risk of heart failure independent of nighttime sleep, comorbidities, and cardiovascular disease/risk factors. What Are the Clinical Implications? Excessive daytime napping may represent preclinical evidence for heart failure. The results call for closer attention to monitoring daytime sleep behavior to optimize cardiovascular health in the older population. Actigraphic daytime sleep monitoring can be valuable as a scalable and easily implemented tool for timely identification of individuals at risk of heart failure. Adequate nighttime sleep of good quality has increasingly been recognized as beneficial to cardiovascular health. 1 Typically defined by short sleep periods during daylight hours, daytime napping is a common practice worldwide. 2 It may be a direct consequence of inadequate or poor nighttime sleep, particularly in older adults, leading to daytime sleepiness. Daytime napping may also reflect a covert symptom of undiagnosed disease such as heart failure (HF) and occur because of fatigue associated with HF. 3 While the association between HF and excessive daytime sleepiness has been reported in cross‐sectional studies, 4 there remains a paucity of prospective studies of daytime napping. Therefore, this longitudinal study was designed to examine the effect of daytime napping behavior on the development of HF. Many studies have suggested that daytime napping is detrimental to cardiovascular disease. 5 , 6 , 7 For example, longer self‐reported daytime napping saw an increased risk for HF in older men. 8 However, others found that daytime napping can be beneficial. 2 , <a class="tab-link" href="#j -Abstract Truncated-

cardiac & cardiovascular systems
Sustained oximetric desaturation as a cardiac risk indicator remains correlated with nonspecific sleep apnea indices.

Skjodt,N.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5347

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:BACKGROUND: Sustained oximetric desaturation is a risk factor for cardiac morbidity and mortality in sleep apnea, Traditional sleep apnea indices are not as predictive. AIM: To model the effects of two indicators of sleep apnea severity on sustained oximetric desaturation. METHODS: Exploratory data analysis and an analysis of covariance (ANCOVA) were performed on an anonymized convenience sample of 5000 ambulatory sleep polygraphs. The ANCOVA modelled the effects of apnea-hypopnea index (AHI, events/h) and the percentage of recording time with inspiratory flow limitation (IFL, %) on the percentage of time with SpO2 < 90% (Under90, %). RESULTS: The medians (and interquartile ranges) for Under90, AHI, and IFL were 7.3 (0.01, 29.3)%, 12.7 (6.6, 23.6)/h, and 17.7 (6.4, 24.9)%. The sums of squares for AHI, IFL, AHI:IFL, and residuals were 52.5, 0.8, 0.3, and 332.1. The F scores and Pr(>F) for AHI, IFL, and AHI:IFL were 880.7 (p << 0.001), 13.4 (p = 0.002), and 5.6 (p=0.018). CONCLUSIONS: The time with SpO2 < 90%, a risk factor for cardiac morbidity and mortality, strongly correlated with AHI and less so with IFL, two insensitive markers for cardiac morbidity and mortality. Further modelling including epidemiological risk scores such as the Framingham score and other polysomnogram risk factors such as pulse wave amplitude variation may improve cardiac risk prediction with sleep apnea.

respiratory system
[Alcoholic dementia with hypomagnesemia, hypocalcemia and hypoparathyroidism].

M. Tsuji,A. Katoh,T. Nakajima

1987-12-01

Abstract:
A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea

Sairam Parthasarathy,Danielle Hyman,James Doherty,Ragy Saad,Jerry Zhang,Susan Morris,Lev Eldemir,Benjamin Fox,Mai Ka Ying Vang,Jessica Schroeder,Nell J Marshall,Gregory S Parks

DOI: https://doi.org/10.1016/j.sleep.2023.12.011

Abstract:Objectives/background: To estimate prevalence and severity of excessive daytime sleepiness among patients with obstructive sleep apnea (OSA) who were prescribed treatment; assess perception and satisfaction of OSA-related care; describe relationships between excessive daytime sleepiness, treatment adherence, and patient satisfaction. Patients/methods: A national population-based cross-sectional sample of US adults with clinician-diagnosed OSA was surveyed in January 2021 via Evidation Health's Achievement App. Patients completed the Epworth Sleepiness Scale, rated satisfaction with healthcare provider and overall OSA care, and reported treatment adherence. Covariates affecting excessive daytime sleepiness (average weekly sleep duration, treatment adherence, sleepiness-inducing medications, age, sex, body mass index, nasal congestion, smoking status, and comorbidities) were adjusted in multivariate regression models. Results: In 2289 participants (50.3 % women; 44.8 ± 11.1 years), EDS was highly prevalent (42 %), and was experienced by 36 % of patients with high positive airway pressure (PAP) therapy adherence. Each additional hour of nightly PAP use was associated with improved sleepiness (a 0.28-point lower Epworth score; p < 0.001). Excessive daytime sleepiness was associated with lower patient satisfaction with healthcare providers and overall care (OR [95 % CI] 0.62 [0.48-0.80] and 0.50 [0.39-0.64], respectively; p < 0.0001), whereas PAP adherence was associated with higher patient satisfaction (OR [95 % CI] 2.37 [1.64-3.43] and 2.91 [2.03-4.17]; p < 0.0001), after adjusting for confounders. Conclusions: In a real-world population-based study of patients with OSA, excessive daytime sleepiness was highly prevalent and associated with poor patient satisfaction ratings. Better patient-centered care among patients with OSA may require interventions aimed at addressing excessive daytime sleepiness and treatment adherence.
0726 Visceral adiposity and daytime sleepiness are associated with hypertension in mild-to-moderate sleep apnea: age-related differences

Efthalia Karagkouni,Alexandros Vgontzas,Julio Fernandez-Mendoza,Kristina Lenker,Maria Basta,Venkatesh Krishnamurthy,Edward Bixler

DOI: https://doi.org/10.1093/sleep/zsac079.722

IF: 6.313

2022-06-04

SLEEP

Abstract:IntroductionMild-to-moderate obstructive sleep apnea (OSA) affects 15-40% of the adult general population and is associated with incident hypertension, particularly in young and middle-aged adults. We examined whether visceral adiposity, a key predictor of OSA, and excessive daytime sleepiness (EDS), a cardinal symptom of OSA, are associated with hypertension in middle-aged and older adult patients with mild-to-moderate OSA.MethodsA clinical sample of 148 adults (53.79±12.45y, 36.5% female) with mild-to-moderate OSA (5≤AHI<30) underwent 8-hour polysomnography, a clinical history and physical examination, including measures of blood pressure. EDS was defined as an Epworth Sleepiness Scale (ESS) score ≥11. Hypertension was defined as blood pressure ≥140/90mmHg or the use of anti-hypertensive medication. Visceral Adiposity Index (VAI) was calculated within each sex using Amato et al (2010) standardized formulas based on waist, BMI, triglycerides and HDL cholesterol. Logistic regression models examined the association between VAI, AHI and EDS with hypertension, adjusting for sex and stratifying by age. Under the receiver-operating characteristics (ROC) curves (AUC) with sex, BMI, AHI, VAI and EDS as independent variables examined predictive risk of hypertension.ResultsVAI (OR=1.64, 95%CI=1.23-2.20, p=0.001) and EDS (OR=2.73, 95%CI=1.04-7.17, p=0.042), but not AHI (OR=1.05, 95%CI=0.98-1.13, p=0.165), were associated with significantly increased odds of hypertension in adults aged <60y (46.81±8.83y), while none of these associations were significant in adults aged ≥60y (67.06±5.65y). Adding VAI and EDS to standard clinical factors (age, sex, and BMI) yielded a strong risk model for hypertension in adults aged <60y (AUC= 0.80), and weaker in adults aged ≥60y (AUC=0.62).ConclusionThese data indicate that the combination of visceral adiposity and subjective sleepiness improves markedly the ability for clinicians to detect cases of mild-to-moderate OSA with increased cardiovascular risk, an association that is strongest in young and middle-aged adults. These findings also further support that OSA in older subjects is a distinctly different phenotype than in young and middle-aged adults.Support (If Any)

neurosciences,clinical neurology
Sleep-Disordered Breathing in Patients with Chronic Heart Failure and Its Implications on Real-Time Hemodynamic Regulation, Baroreceptor Reflex Sensitivity, and Survival

Anna S. Lang-Stöberl,Hannah Fabikan,Maria Ruis,Sherwin Asadi,Julie Krainer,Oliver Illini,Arschang Valipour

DOI: https://doi.org/10.3390/jcm13237219

IF: 3.9

2024-11-28

Journal of Clinical Medicine

Abstract:Background: Impairment in autonomic activity is a prognostic marker in patients with heart failure (HF), and its involvement has been suggested in cardiovascular complications of obstructive sleep apnea syndrome (OSAS) and Cheyne–Stokes respiration (CSR). This prospective observational study aims to investigate the implications of sleep-disordered breathing (SDB) on hemodynamic regulation and autonomic activity in chronic HF patients. Methods: Chronic HF patients, providing confirmation of reduced ejection fraction (≤35%), underwent polysomnography, real-time hemodynamic, heart rate variability (HRV), and baroreceptor reflex sensitivity (BRS) assessments using the Task Force Monitor. BRS was assessed using the sequencing method during resting conditions and stress testing. Results: Our study population (n = 58) was predominantly male (41 vs. 17), with a median age of 61 (±11) yrs and a median BMI of 30 (±5) kg/m2. Patients diagnosed with CSR were 13.8% (8/58) and 50.0% (29/58) with OSAS. No differences in the real-time assessment of hemodynamic regulation, heart rate variability, or baroreceptor reflex function were found between patients with OSAS, CSR, and patients without SDB. A subgroup analysis of BRS and HRV in patients with severe SDB (AHI > 30/h) and without SDB (AHI < 5) revealed numerically reduced BRS and increased LF/HF-RRI values under resting conditions, as well as during mental testing in patients with severe SDB. Patients with moderate-to-severe SDB had a shorter overall survival, which was, however, dependent upon age. Conclusions: Chronic HF patients with severe SDB may exhibit lower baroreceptor function and impaired cardiovascular autonomic function in comparison with HF patients without SDB.

medicine, general & internal
Objective Sleep Duration and All-Cause Mortality among People with Obstructive Sleep Apnea

Yiqi Lin,Yongxi Wu,Qianwen Lin,Yun Kwok Wing,Lili Xu,Junbo Ge,Qinwei Wu,Zhen Li,Qingjie Wu,Beiwei Lin,Shichao Wei

DOI: https://doi.org/10.1001/jamanetworkopen.2023.46085

2023-01-01

JAMA Network Open

Abstract:Importance The association between sleep duration and all-cause mortality remains unclear among people with obstructive sleep apnea (OSA).Objective To explore whether there is an association between sleep duration and all-cause mortality among people with OSA.Design, Setting, and Participants This cohort study investigated participants with OSA from the Sleep Heart Health Study (SHHS) in which participants were enrolled between 1995 and 1998 with questionnaires and polysomnography (PSG) assessment and followed up for a median of 11.8 years. SHHS was a multicenter community-based study; 2574 participants with OSA defined by apnea-hypopnea index (AHI) greater than or equal to 15 from SHHS were found; all of them had all-cause mortality data and were included in the study. Data were analyzed from November 2022 to October 2023.Exposures Participants were divided into 4 groups with objective sleep duration of (1) at least 7 hours, (2) 6 to less than 7 hours, (3) 5 to less than 6 hours, and (4) less than 5 hours, which was determined by total sleep time on PSG at baseline.Main Outcomes and Measures All-cause mortality was defined as deaths from any cause and its risk was compared among 4 OSA groups using Cox regression models.Results A total of 2574 participants with OSA were included (1628 [63.2%] men and 946 [36.8%] women; mean [SD] age, 65.4 [10.7] years; 211 [8.2%] Black, 2230 [86.6%] White, 133 [5.2%] other race). Overall, 688 all-cause deaths were observed in participants. Compared with the group sleeping at least 7 hours, the groups sleeping 6 to less than 7 hours (hazard ratio [HR], 1.53 [95% CI, 1.13-2.07]), 5 to less than 6 hours (HR, 1.40 [95% CI, 1.03-1.90]), and less than 5 hours (HR, 1.64 [95% CI, 1.20-2.24]) had significantly higher risks of all-cause mortality independent of AHI. Sensitivity analyses were performed among participants with available data of positive airway pressure treatment during follow-up and the finding was mostly consistent, albeit the HR for the group of 5 to less than 6 hours was not statistically significant.Conclusions and Relevance In this cohort study of 2574 participants with OSA, those with shorter objective sleep duration had higher risk of all-cause mortality independent of AHI compared with those sleeping at least 7 hours. Further studies would be needed to investigate health benefits of extending sleep length among people with OSA with short sleep duration.
An innovative phonological therapy programme.

D. Ingram,K. Ingram

DOI: https://doi.org/10.1080/136828299247621

1999-01-03

Abstract:
Sleep Abnormalities Among Community Participants At Risk For Heart Failure

Yogesh N.V. Reddy,Susan DeFranco,John Park,Amir Lerman,Virend Somers,Barry Borlaug

DOI: https://doi.org/10.1016/j.cardfail.2023.10.044

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Sleep abnormalities are associated with metabolic health and underlying heart failure (HF). HF with preserved Ejection Fraction (HFpEF) is the most common cause of HF but is severely underdiagnosed given the limitations in current diagnostic criteria. Therefore, we sought to determine self-reported and directly recorded sleep abnormalities using custom fitted beds capable of physiological monitoring (SleepNumber Co) among community-dwelling participants who were at risk of HFpEF. Methods We first developed a regression equation to estimate the probability of HFpEF using age and body mass index in a derivation cohort where the diagnosis of HFpEF was definitively confirmed or refuted conclusively using gold standard diagnosis with exercise right heart catheterization demonstrating elevated exercise pulmonary capillary wedge pressure. This was validated in an independent cohort with similar gold standard diagnosis. We then estimated the probability of HFpEF in community participants at risk for HFpEF and compared directly recorded sleep data averaged over a month of observation in 91954 Sleep Number bed users, as well as self reported Sleep survey data in a subset (n=5861) of these participants. Results The HFpEF prediction algorithm based on age and BMI had good discrimination in the derivation (AUC 0.806 [95% CI 0.761-0.850], p<0.0001) and validation cohort (AUC 0.770 [95% CI 0.730-0.810], p<0.0001). Comparing individuals with a high probability (>75%) of HFpEF (HFpEFhighprob) with those with a low probability (<25%) of HFpEF (HFpEFlowprob), those with HFpEFhighprob were more likely to report taking regular naps during the day (16.4% vs 11.2%, p<0.0001) and never exercise (24.4 vs 17.7%, p<0.0001). The HFpEFhighprob group were also more likely to have self-reported sleep disturbances 7 days a week (36% vs 19%, p<0.0001), nocturia requiring awakening at night (69% vs 45%, p<0.0001), and sleep problems present for more than a year (76% vs 64%, p<0.0001). These sleep disturbances in HFpEFhighprob occurred despite a lower proportion reporting difficulty falling asleep (31% vs 40%, p<0.0001), similar objectively measured average hours slept across groups (median 8.4 [IQR 7.0-10.3] vs 8.6 hours [7.2-10.3], p=0.11) and less awakening episodes per night (median 3 [IQR 3-5] vs 4 [3-5], p=0.0003) suggesting impaired quality of sleep rather than duration. The HFpEFhighprob also demonstrated greater fluctuations in peak and trough sleep motion, respiration and HR indices, and greater HR variability throughout sleeping sessions (p<0.0001 for all) compared to HFpEFlowprob. Conclusion Self reported and objective sleep abnormalities in physiological indices and quality of sleep are commonly observed in community participants at high risk for HFpEF. Given the impaired quality of life in HFpEF, further study of the true prevalence and impact of sleep disorders in HFpEF are urgently needed.

cardiac & cardiovascular systems
Nocturnal Cardiac Arrhythmias in Heart Failure with Obstructive and Central Sleep Apnea

Christian M Horvath,Christoph Fisser,John S Floras,Samuel Sossalla,Stella Wang,George Tomlinson,Fiona Rankin,Shoichiro Yatsu,Clodagh M Ryan,T Douglas Bradley,Michael Arzt,ADVENT-HF Investigators

DOI: https://doi.org/10.1016/j.chest.2024.08.003

IF: 9.6

2024-08-19

Chest

Abstract:Background: Both obstructive and central sleep apnea (OSA and CSA) may contribute to nocturnal cardiac arrhythmias (NCA). Data on the prevalence of clinically important nocturnal atrial and ventricular arrythmias in patients with heart failure with reduced ejection fraction (HFrEF) and obstructive (OSA) or central sleep apnea (CSA) are scarce. Research questions: In a cohort of patients with HFrEF, how does the prevalence of NCA compare among those with OSA, CSA and those with no to mild sleep apnea? Is the severity of OSA or CSA associated with atrial and ventricular NCA? Methods: This cross-sectional analysis is an ancillary study of the ADVENT-HF trial. We compared the prevalence of NCA (excessive supraventricular ectopic activity [ESVEA], defined as premature atrial complexes [PAC] ≥30/h or supraventricular tachycardia ≥20 beats); atrial fibrillation/flutter [AF]; and >10 premature ventricular complexes [PVC/h]) on ECGs from polysomnograms of HFrEF patients between those with OSA (apnea-hypopnea index [AHI≥15]), those with CSA (AHI≥15/h) and those with no to mild sleep apnea (AHI<15, control). Results: Compared to controls (n=76), the prevalence of ESVEA was higher in patients with OSA (n=430) and CSA (n=150), 0%, 9% and 12%, respectively. The prevalences of AF in the control, OSA and CSA groups were 9%, 17% and 27%, and of >10 PVC/h 45%, 59% and 63%, respectively. In multivariable regression analyses PAC/h was associated with OSA severity (obstructive AHI) [22.4% increase per 10 events/h (95% confidence interval: 5.2; 42.3); p=0.009], but neither obstructive nor central AHI were associated with AF or >10 PVC/h. Interpretation: In patients with HFrEF, the prevalences of nocturnal ESVEA, AF and PVC >10/h were higher in those with, than in those without OSA or CSA, and OSA severity was related to the burden of nocturnal atrial ectopy. Severity of OSA or CSA were not significantly related to AF or >10 PVC/h.
Abstract 18481: Paroxysmal Atrial Fibrillation and Sleep Apnea: Diurnal Patterning of Autonomic Function and Influence of CPAP Therapy

Sepideh Khazaie,Lu Wang,kaffashi farhad,Ahana Sandhu,Mina K Chung,Catherine M Heinzinger,David R Van Wagoner,Kenneth Loparo,Reena Mehra

DOI: https://doi.org/10.1161/circ.148.suppl_1.18481

IF: 37.8

2023-11-07

Circulation

Abstract:Introduction: Autonomic nervous system (ANS) dysfunction is implicated in sleep-disordered breathing (SDB) and atrial fibrillation (AF). Hypothesis: We hypothesize that ANS measures of heart rate variability (HRV) exhibit diurnal differences in paroxysmal AF(PAF) relative to SDB severity and is impacted by continuous positive airway pressure (CPAP). Methods: Data from the Sleep Apnea and Atrial Fibrillation Biomarkers and Electrophysiologic Atrial Triggers (SAFEBEAT) study including PAF (7-24 day ECG monitoring), concomitant actigraphy and SDB from polysomnography at baseline and 3-months post-CPAP were analyzed. Linear mixed-effects models were used to assess SDB (apnea hypopnea index (AHI), hypoxia (%sleep time with SaO2<90% and nadir SaO2) and diurnal average HRV (frequency domain (sympathovagal)): low-frequency range (LF), high-frequency range (HF), LF/HF; time domain: mean of normal RR interval (MNN), standard deviation of NN intervals (SDNN), SD1(Poincare plot standard deviation) and effect of 3-month CPAP. Results: In 44869 five-minute epochs from 109 participants with SDB and PAF, during wakefulness, associations of AHI and LFP, nadir SaO2 with sympathovagal measures (LFP, LHR) and time domain measures (SDNN, SD2) were observed. A sleep-wake significant interaction was observed with all HRV measures and stronger associations in wake than sleep. Baseline to follow-up CPAP time domain measures were increased during wakefulness (MNN, SDNN, RMSSD, CV, SD1, and SD2) and increased during sleep (MNN, SD2, LHR). Conclusions: Diurnal variation of autonomic measures in moderate to severe SDB was observed and association with SDB severity was more pronounced during wakefulness; CPAP influenced autonomic function. These findings in earlier onset AF may contribute to electrophysiological remodeling with implications for ANS-specific chronobiology in SDB.

cardiac & cardiovascular systems,peripheral vascular disease
0520 Relationship Between ESS and AHI in PSG vs. HSAT: Possible Modulation by Sex

Mc Lyne Lynch,Boris Dubrovsky,Jeremy Weingarten,John Cunningham

DOI: https://doi.org/10.1093/sleep/zsae067.0520

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Excessive daytime sleepiness is a major symptom of OSA. However, the relationship between Epworth Sleepiness Scale (ESS) and apnea-hypopnea index (AHI) is tenuous and may depend on whether the AHI is derived from an in-lab or at-home study. We analyzed ESS as a function of demographic variables and AHI in a group of patients evaluated with type 3 home sleep apnea test (HSAT) or in-the lab PSG. Methods A group of 83 HSAT patients (40 women) were matched with 83 PSG patients by race and sex. Additionally, age was matched within a decade (20-29, 30-39, etc.), and BMI was matched within ±2.5 units. ESS was regressed onto age, BMI, sex, AHI, and AHI-by-sex, AHI-by-HSAT/PSG and AHI-by-sex-by-HSAT/PSG interactions in a backward regression model. Results The mean AHI=18.0±20.0, 119 patients had AHI≥5.0, OSA severity was equally represented on HSAT and PSG studies (chi-square=0.51, p=0.92). ESS was negatively related to AHI (B=-0.58, SE=0.25, p=0.022); however, all three interaction terms were significant: AHI-by-sex (B=0.30, SE=0.14, p=0.030), AHI-by-HSAT/PSG (B=0.37, SE=0.14, p=0.009) and AHI-by-sex-by-HSAT/PSG (B=0.20, SE=0.08, p=0.013). Analyzing men and women separately, women evidenced a negative relationship between ESS and AHI (B=-0.29, SE=0.13, p=0.023) and a significant AHI-by-HSAT/PSG interaction (B=0.18, SE=0.07, p=0.009). Among men, no explanatory variables or interaction terms were significantly related to ESS. Conclusion As suggested by this limited sample, the relationship between AHI and self-reported daytime sleepiness may depend on the type of test used to evaluate the respiratory status and may also be modulated by the patient’s sex. Future studies are required to elucidate the interaction between sex, AHI and the type of apnea test in the effects of these variables on subjective daytime sleepiness. Support (if any) none

neurosciences,clinical neurology

Complexes of nickel(II) with purine bases: relaxation spectra.

Poor Sleep Quality And Excessive Daytime Sleepiness Are Associated With Adverse Health Outcomes In Patients With Heart Failure

HISTIOCYTOSIS X WITH CATECHOLAMINE EXCESS

[Effect of Objective Daytime Sleepiness on Heart Rate Variability in Patients With Obstructive Sleep Apnea].

Sleep apnea is associated with reduced in-hospital mortality in patients admitted for acute heart disease

Obstructive sleep apnoea and nocturnal atrial fibrillation in patients with ischaemic heart disease

0490 Sleep Apnea Severity Has a U-shaped Association with All-cause Mortality

Heart rate variability analysis in obstructive sleep apnea patients with daytime sleepiness

Gene directed enzyme prodrug therapy for cancer.

Objective Assessment of Daytime Napping and Incident Heart Failure in 1140 Community-Dwelling Older Adults: A Prospective, Observational Cohort Study.

Sustained oximetric desaturation as a cardiac risk indicator remains correlated with nonspecific sleep apnea indices.

[Alcoholic dementia with hypomagnesemia, hypocalcemia and hypoparathyroidism].

A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea

0726 Visceral adiposity and daytime sleepiness are associated with hypertension in mild-to-moderate sleep apnea: age-related differences

Sleep-Disordered Breathing in Patients with Chronic Heart Failure and Its Implications on Real-Time Hemodynamic Regulation, Baroreceptor Reflex Sensitivity, and Survival

Objective Sleep Duration and All-Cause Mortality among People with Obstructive Sleep Apnea

An innovative phonological therapy programme.

Sleep Abnormalities Among Community Participants At Risk For Heart Failure

Nocturnal Cardiac Arrhythmias in Heart Failure with Obstructive and Central Sleep Apnea

Abstract 18481: Paroxysmal Atrial Fibrillation and Sleep Apnea: Diurnal Patterning of Autonomic Function and Influence of CPAP Therapy

0520 Relationship Between ESS and AHI in PSG vs. HSAT: Possible Modulation by Sex